A Phase I, Double Blind, Randomized, Placebo Controlled, Maximal Dose Study to Determine the Safety, Tolerability of Topical Cream Containing MGC (Medical Grade Cannabis) in Healthy Volunteers

Trial Profile

A Phase I, Double Blind, Randomized, Placebo Controlled, Maximal Dose Study to Determine the Safety, Tolerability of Topical Cream Containing MGC (Medical Grade Cannabis) in Healthy Volunteers

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 02 Dec 2016

At a glance

  • Drugs Marijuana (Primary)
  • Indications Psoriasis
  • Focus Adverse reactions
  • Sponsors One World Cannabis
  • Most Recent Events

    • 11 Oct 2016 According to an OWC Pharmaceuticals Research Corp media release, this trial will start upon receiving the Institutional Review Board (IRB) approval by the national IRB committee which is expected to be assembled in November 2016.
    • 11 Mar 2016 New trial record
    • 09 Mar 2016 According to OWC Pharmaceuticals media release, company has finished the IRB (Institutional Review Board) protocol for this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top